J. Arsène

Immunogenicity and safety of measles-mumps-rubella-varicella (MMRV) vaccine followed by one dose of varicella vaccine in children aged 15 months-2 years or 2-6 years primed with measles-mumps-rubella (MMR) vaccine.

S. Esposito, M. Desole, U. Behre, 2009, Vaccine.

Immunogenicity of the 10-Valent Pneumococcal Non-typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) Compared to the Licensed 7vCRM Vaccine

T. Vesikari, I. Dieussaert, H. Czajka, 2009, The Pediatric infectious disease journal.